Novalis LifeSciences, based in New Hampshire, backs life sciences specialists, with $500M across three funds, and has invested in Cerevel Therapeutics and Ginkgo Bioworks.
3 people on the investing team, 2 of them partners who can make the call. Partners are listed first.

Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Novalis LifeSciences has not reported an entry stage.
Novalis LifeSciences has not reported a check size.
Novalis LifeSciences has not reported a lead preference.
Devin Leake (Managing Director), Paul Meister (Partner).
No recent activity since September 2026.
Work at Novalis LifeSciences? Claim or correct this profile.